查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049635

化學資訊學市場規模、佔有率、趨勢和預測：按應用和地區分類，2026-2034年

Chemoinformatics Market Size, Share, Trends and Forecast by Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年全球化學資訊學市場規模為73億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以7.28%的複合年成長率成長，到2034年達到140億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過43.6%。推動全球市場成長的因素包括：藥物研發需求不斷成長、慢性病盛行率上升、人工智慧（AI）、機器學習（ML）和巨量資料分析技術的進步、個人化醫療需求的日益成長、研發投入的增加、產業間的策略聯盟以及在製藥、生物技術和學術研究領域應用範圍的不斷擴大。

全球化學資訊學市場的成長主要受個人化醫療需求不斷成長的推動，進而促使人們對高效藥物發現和開發流程的需求日益增加。此外，計算化學、機器學習和巨量資料分析領域的持續技術進步正在改善分子建模和虛擬篩檢，縮短研究週期，從而加速市場發展。同時，製藥和生技公司加大研發投入也促進了市場成長。例如，一項針對130多位生技主管的產業調查顯示，60%的受訪者正在考慮增加研發支出，而只有2%的受訪者預計會減少研發投入。儘管受訪者對產品成功持樂觀態度，但32%的受訪者認為臨床試驗的複雜性是該領域最大的障礙。該報告還揭示了資金籌措策略，其中48%的受訪者選擇與製藥公司合作，32%的受訪者選擇創業投資。因此，策略外包和合作夥伴關係對於最大限度地提高臨床開發效率和吸引投資至關重要。政府為創新醫療保健解決方案所採取的舉措，以及學術機構和產業相關人員之間的合作，正在進一步擴大化學資訊學工具的應用，進而推動全球市場成長。

美國化學資訊學市場的發展主要得益於藥物發現和研發的持續進步，而這又源自於人們對個人化和精準醫療日益成長的需求。包括癌症和神經系統疾病在內的慢性病盛行率不斷上升，迫使製藥公司加快研發步伐，進一步推高了對化學資訊工具的需求。例如，2024年3月14日發表在《柳葉刀神經病學》上的一項研究估計，2021年全球有超過30億人患有神經系統疾病。這些疾病如今已超過其他所有病因，成為導致疾病和殘疾的主要原因，自1990年以來，失能調整後存活年（DALYs）增加了18%。超過80%的神經系統疾病導致的死亡和健康損失發生在低收入和中等收入國家，凸顯了醫療保健資源分配方面存在的巨大不平等。人工智慧和巨量資料分析的融合正在簡化分子建模和化合物分析流程，進一步推動市場成長。此外，政府支持數位醫療轉型和加大研發投入的措施正在促進創新並擴大市場。

化學資訊學市場趨勢：

透過人工智慧和機器學習的融合實現成長

人工智慧和機器學習的融合正在加速化學研發活動，並重塑化學資訊學市場。根據業界報告顯示，人工智慧和機器學習技術可將藥物發現週期縮短高達50%，進而減少識別有效化合物所需的時間。人工智慧模型（例如用於預測分子性質的模型）使研究人員能夠以前所未有的速度和精度模擬化學反應並分析數據。這最大限度地減少了試驗，並加快了研究進展。人工智慧驅動的化學資訊學工具已被證明可將研究成本降低約40%，使其成為製藥公司和學術研究機構不可或缺的工具。預計這些進步將在未來幾年透過提高藥物發現和材料開發的效率、推動新產品創新以及加速醫學、材料和技術領域的新發展，推動該市場的快速成長。

在藥物發現領域不斷拓展的應用

化學資訊學正穩步確立其在藥物發現領域的關鍵地位，其工具擴大應用於分子結構分析和生物活性預測。事實上，根據一份產業報告顯示，目前超過75%的新藥研發都運用了化學資訊學工具進行分子分析、化合物篩檢和先導化合物。化學資訊學還能減少成本高且耗時的實驗室實驗，進而加速藥物發現進程。隨著數據驅動型藥物發現的不斷發展，化學資訊學的角色將更加重要，應用範圍也將不斷擴大。預計這將進一步提振化學資訊學市場前景，使製藥公司能夠以最低的成本實現高效的藥物發現流程，並確保患者獲得更好的治療效果。

擴大雲端平台的使用

雲端平台正在改變研究機構和製藥公司部署和使用化學資訊學工具的方式。產業報告顯示，雲端技術的應用正在加速化學數據的處理。雲端基礎設施提供的敏捷性和擴充性使研究人員能夠儲存和處理大規模資料集，促進遠端協作，並存取複雜的化學資訊學工具，而無需在本地建立大規模基礎設施。根據Avaahi Tech發布的2024年報告，製藥公司透過採用雲端服務，平均降低了30%的IT營運成本，從而實現了更有效率、更經濟的研發和營運。雲端運算通常也有助於跨學科的資料共用和協作，從而加速創新。雲端平台不斷發展，並在加速研發和藥物發現（尤其是在高通量環境下）方面發揮越來越重要的作用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球化學資訊學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依應用領域分類

  • 化學分析
  • 藥物發現
  • 藥物驗證
  • 其他

第7章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第8章 SWOT 分析

第9章：價值鏈分析

第10章：波特五力分析

第11章：價格分析

第12章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioSolveIT GmbH
    • BIOVIA（Dassault Systemes）
    • ChemAxon Inc.
    • Eurofins CEREP SA（Eurofins Panlabs Inc.）
    • Jubilant Biosys Inc.
    • Molecular Discovery Ltd.
    • OpenEye Scientific Software Inc.
    • Schrodinger Inc.
Product Code: SR112026A3928

The global chemoinformatics market size was valued at USD 7.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 14.0 Billion by 2034, exhibiting a CAGR of 7.28% from 2026-2034. North America currently dominates the market, holding a significant market share of over 43.6% in 2025. The global market is driven by rising demand for drug discovery, increasing prevalence of chronic diseases, advancements in artificial intelligence (AI), machine learning (ML), big data analytics, growing need for personalized medicine, increased research and development (R&D) investments, strategic industry collaborations, and expanding applications in pharmaceutical, biotechnology, and academic research sectors.

The global chemoinformatics market growth is majorly driven by the increasing need for efficient drug discovery and development processes, fueled by rising demand for personalized medicine. Moreover, ongoing technological advancements in computational chemistry, ML, and big data analytics are improving molecular modeling and virtual screening, accelerating research timelines, thereby fostering the market. Additionally, growing investments from pharmaceutical and biotechnology companies into R&D initiatives are propelling market growth. For instance, as per industry reports, a survey of +130 biotech executives revealed that 60% of biotechs intend to increase their R&D spending, whereas only 2% expect cuts. Even though respondents were optimistic about the success of products, 32% named the complexity of clinical trials as the most significant obstacle in the segment. Funding strategies were also exposed in the report, and 48% used pharmaceutical partnerships while 32% used venture capital. Therefore, both strategic outsourcing and collaboration proved important to maximize clinical development and attract investment. Government initiatives for innovative healthcare solutions and collaborations between academic institutions and industry players are further expanding the adoption of chemoinformatics tools, which in turn is fostering market expansion globally.

The United States chemoinformatics market demand is driven by ongoing advancements in drug discovery and development spurred by the increase in demand for personalized medicine and precision therapeutics. A rising prevalence of chronic diseases, including cancers and neurological disorders, is compelling pharmaceutical companies to speed up the research processes that have increased the demand for chemoinformatics tools. For instance, on 14 March 2024, a study published in The Lancet Neurology reported that in 2021 more than 3 billion people worldwide were living with neurological conditions. The conditions have surpassed all other causes to become the largest driver of illness and disability and currently account for an increase of 18% more associated disability-adjusted life years (DALYs) since 1990. More than 80% of neurological deaths and health losses happen in low- and middle-income countries, thereby calling attention to major inequalities in accessing healthcare. Integration of AI and big data analytics is streamlining molecular modeling and compound analysis, which further propels the growth of the market. Furthermore, government initiatives supporting digital healthcare transformation and increased investments in R&D are fostering innovation, thereby expanding the market.

CHEMOINFORMATICS MARKET TRENDS:

GROWTH IN AI AND MACHINE LEARNING INTEGRATION

The integration of AI and ML is enhancing the speed of chemical R&D activities, transforming the chemoinformatics market trends. Industrial reports show that AI and ML technology reduce the timeline of drug discovery by up to 50%, thereby accelerating how long it takes to identify useful compounds. AI models, such as those used to predict molecular properties, enable researchers to simulate chemical reactions and analyze data with unprecedented speed and accuracy. This leads to faster research through minimal trial and error. With AI-driven chemoinformatics tools, research has been proven to reduce the costs associated with it by about 40%, making it a much-needed tool for pharmaceutical and academic research institutions. These advancements are also improving the efficacy of drug discovery as well as material development, and thereby innovating new products, potentially giving rise to medical treatments, materials, and technology, thereby resulting in the rapid growth of this market in the coming years.

RISE IN DRUG DISCOVERY APPLICATIONS

Chemoinformatics is progressively becoming one of the key areas in drug discovery, with tools that are increasingly used in analyzing molecular structures and predicting biological activity. In fact, according to an industrial report, more than 75% of new drug discoveries now use the tools of chemoinformatics for molecular analysis, compound screening, and predictions of toxicity. This trend has made it increased by 60% to the computation methods applied in drug discovery in the last five years. These tools have the capability of identifying promising candidates for drugs with a much shorter period due to predictions in molecular interactions and optimization of lead compounds. Chemoinformatics also serves to speed up the drug development process by lessening the costly and time-consuming lab experiments involved. Further ahead with the data-driven evolvement of drug discovery, the role of chemoinformatics would be more in demand and growing, thereby providing pharmaceuticals the capacity for an efficient drug development process with minimal cost, ensuring a better outcome for patients and enhancing the chemoinformatics market outlook.

INCREASING ADOPTION OF CLOUD-BASED PLATFORMS

Cloud-based platforms are changing the mode of operation for chemoinformatics tool deployment and accessibility among research institutes and pharmaceutical firms. According to industrial reports, the adoption of cloud has quickened the processing of chemical data. The agility and scalability offered by cloud infrastructure enable researchers to store and process large datasets, facilitate collaboration from a distance, and avail complex chemoinformatics tools without needing a large infrastructure on-site. A 2024 report by Avaahi Tech reveals that pharmaceutical companies achieve an average 30% reduction in IT operational costs by adopting cloud services, enabling more efficient and cost-effective research and operations. Cloud computing, in general, also supports easier data sharing and collaboration across disciplines, thereby furthering innovation. As cloud-based platforms continue to change, they play an increasingly vital role in accelerating research and enabling breakthroughs in drug development, particularly in high-throughput environments.

CHEMOINFORMATICS INDUSTRY SEGMENTATION:

ANALYSIS BY APPLICATION:

  • Chemical Analysis
  • Drug Discovery
  • Drug Validation
  • Others

The chemical analysis leads with around 30.0% of the chemoinformatics market share in 2025. It plays a very crucial role in drug discovery, material science, and quality control processes. This will be essential in developing new pharmaceuticals and chemical products as it accurately identifies, characterizes, and validates compounds. With increasing molecular structure complexity, demand for analytical tools and software will continue to rise to obtain more accurate data. In addition, pharmaceutical, agriculture, and environmental science industries greatly rely on chemical analysis for regulation and innovation purposes. Chemical analysis is being further dominated by these elements within the scope of chemoinformatics.

REGIONAL ANALYSIS:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 43.6%. North America is the leader in the chemoinformatics market, as it has a strong pharmaceutical and biotechnology sector, which makes significant investments in drug discovery and development. Additionally, the rising incidence of chronic diseases and the growing demand for personalized medicine are propelling research efforts. Supportive policies from the government, strong investment in healthcare innovations, and mutual collaborations between research institutions and private players are driving North America's dominance in the chemoinformatics market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES CHEMOINFORMATICS MARKET ANALYSIS

In 2025, the United States represented 83.60% of the North America passive electronic components market, driven by continual advancements in drug discovery as well as substantial investments in the research and development of chemoinformatics solutions. The fiscal year 2023 witnessed that the U.S. federal government spent about USD 190 Billion in R&D activities, thereby helping the widespread adaptation of chemoinformatics tools in pharmaceutical as well as in academic institutions. Integration of artificial intelligence and machine learning in chemoinformatics accelerates compound screening and molecular analysis. The leaders include BIOVIA and Schrodinger, offering software platforms that are useful for drug design and material sciences. Government support, through the National Institutes of Health (NIH) funding, improves innovation, and thus propels market growth. Apart from this, the home country software development bolster adds another layer of competitive advantage to US-based companies around the globe. The United States remains the top player in chemoinformatics, building upon export opportunities and collaborative alliances to strengthen this position.

EUROPE CHEMOINFORMATICS MARKET ANALYSIS

Europe's chemoinformatics market is moving ahead due to the strict regulations and more pharmaceutical research. Horizon Europe has also granted EUR 95.5 Billion (USD 98.92 Billion) for research programs (2021-2027), and digital tools such as chemoinformatics are used in these drug developments. Germany, France, and the UK are first in using advanced software for molecular modeling, which is primarily due to their large pharmaceutical industries. ChemAxon and Cresset are companies working on new innovations, such as predictive analytics in chemical synthesis. The market is also benefited from the EU policy of open-access platforms for research, thereby creating a bridge between academia and industry. The drive for sustainable chemistry in Europe accelerates the growth of green tools, thereby accelerating the market further.

ASIA PACIFIC CHEMOINFORMATICS MARKET ANALYSIS

The Asia Pacific market is growing with increase in pharmaceutical R&D, as well as academic collaborations. To that extent, the Chinese Ministry of Science and Technology reported that in 2022, USD 441 Billion was allocated to R&D for innovations in drug discovery and computational chemistry. India, through its "Digital India" initiative, encourages the growth of indigenous software development, chemoinformatics thereby is gradually finding footholds in education and commerce. Local startups partner with international companies to advance AI-driven solutions for drug design. Japan and South Korea are also investing in supercomputing capabilities to enhance molecular simulations. The growing demand for precision medicine in the region further supports market expansion. Government-backed initiatives, such as China's AI Pharma program, ensure that the Asia Pacific remains a key player in the global chemoinformatics landscape.

LATIN AMERICA CHEMOINFORMATICS MARKET ANALYSIS

Advances in the pharmaceutical sector and research initiatives are the driving factors behind the growth of the Latin American chemoinformatics market. According to an industry report, in 2023, the Brazilian chemical and pharmaceutical industry achieved a turnover of EUR 105.2 Billion (USD 116.1 Billion), showing a strong potential of the region. Companies in Brazil are increasingly implementing chemoinformatics for improved drug discovery and development. In Mexico and Argentina, research institutions are including computational tools in their programs, further increasing the demand for advanced solutions. Government incentives, including tax benefits for R&D, are driving innovation. Besides, strategic collaboration with global players gives access to cutting-edge technologies, ensuring steady market growth. Moreover, the focus on combating neglected tropical diseases positions Latin America as an emerging contributor to the global chemoinformatics landscape.

MIDDLE EAST AND AFRICA CHEMOINFORMATICS MARKET ANALYSIS

The Middle East and Africa market is expanding due to their investments in health care and research. In 2022, the Saudi Arabian Ministry of Investment reports that the Kingdom allocated USD 37 Billion to healthcare, which included programs for advanced pharmaceutical technologies. A regional leader in biotech research, South Africa becomes increasingly more encompassing using chemoinformatics technologies during its drug discovery processes. International ties provide access to cutting-edge technologies through partnerships with European software developers. The government programs promoting STEM education further add to the market potential. Furthermore, the increased focus on personalized medicine across the region increases the demand for predictive modeling and molecular docking tools, making the market a sustainable growth story.

COMPETITIVE LANDSCAPE:

The market for chemoinformatics is very competitive, with major companies emphasizing on advanced software solutions and platforms with artificial intelligence, machine learning, and big data analytics for streamlining drug discovery and molecular research. Continuous innovation fuels competition, making the firms heavily invest in R&D on developing even more accurate and efficient tools for molecular modeling, cheminformatics, and predictive analytics. Strategic partnerships, collaborations with academic institutions, and acquisitions are all common in order to improve their technological abilities and broaden market reach. The increasing need for personalized medicine and a rise in chronic diseases further enhance this dynamic competitive environment. For instance, On October 21, 2024, Agilent Technologies launched the Infinity III LC Series, featuring enhanced automation, connectivity, and sustainability capabilities. The new systems, including the 1290 Infinity III LC and 1260 Infinity III Prime LC, introduce InfinityLab Assist Technology to streamline operations and minimize errors. This innovation aims to improve lab efficiency, reduce operator workload, and provide greater accuracy through automated routines and advanced sample tracking, reinforcing Agilent's leadership in liquid chromatography solutions.

The report provides a comprehensive analysis of the competitive landscape in the chemoinformatics market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • BioSolveIT GmbH
  • BIOVIA (Dassault Systemes)
  • ChemAxon, Inc.
  • Eurofins CEREP SA (Eurofins Panlabs Inc.)
  • Jubilant Biosys Inc.
  • Molecular Discovery Ltd.
  • OpenEye Scientific Software Inc.
  • Schrodinger Inc.

Key Questions Answered in This Report

  • 1.What is chemoinformatics?
  • 2.How big is the chemoinformatics market?
  • 3.What is the expected growth rate of the global chemoinformatics market during 2026-2034?
  • 4.What are the driving factors of the chemoinformatics market?
  • 5.What is the leading segment of the global chemoinformatics market based on application?
  • 6.Which region leads the global chemoinformatics market?
  • 7.Who are the prominent players operating in the chemoinformatics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Chemoinformatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Chemical Analysis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Discovery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Drug Validation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 United States
      • 7.1.1.1 Market Trends
      • 7.1.1.2 Market Forecast
    • 7.1.2 Canada
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
  • 7.2 Asia-Pacific
    • 7.2.1 China
      • 7.2.1.1 Market Trends
      • 7.2.1.2 Market Forecast
    • 7.2.2 Japan
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Forecast
    • 7.2.3 India
      • 7.2.3.1 Market Trends
      • 7.2.3.2 Market Forecast
    • 7.2.4 South Korea
      • 7.2.4.1 Market Trends
      • 7.2.4.2 Market Forecast
    • 7.2.5 Australia
      • 7.2.5.1 Market Trends
      • 7.2.5.2 Market Forecast
    • 7.2.6 Indonesia
      • 7.2.6.1 Market Trends
      • 7.2.6.2 Market Forecast
    • 7.2.7 Others
      • 7.2.7.1 Market Trends
      • 7.2.7.2 Market Forecast
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Market Trends
      • 7.3.1.2 Market Forecast
    • 7.3.2 France
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Forecast
    • 7.3.3 United Kingdom
      • 7.3.3.1 Market Trends
      • 7.3.3.2 Market Forecast
    • 7.3.4 Italy
      • 7.3.4.1 Market Trends
      • 7.3.4.2 Market Forecast
    • 7.3.5 Spain
      • 7.3.5.1 Market Trends
      • 7.3.5.2 Market Forecast
    • 7.3.6 Russia
      • 7.3.6.1 Market Trends
      • 7.3.6.2 Market Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Trends
      • 7.3.7.2 Market Forecast
  • 7.4 Latin America
    • 7.4.1 Brazil
      • 7.4.1.1 Market Trends
      • 7.4.1.2 Market Forecast
    • 7.4.2 Mexico
      • 7.4.2.1 Market Trends
      • 7.4.2.2 Market Forecast
    • 7.4.3 Others
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Market Forecast
  • 7.5 Middle East and Africa
    • 7.5.1 Market Trends
    • 7.5.2 Market Breakup by Country
    • 7.5.3 Market Forecast

8 SWOT Analysis

  • 8.1 Overview
  • 8.2 Strengths
  • 8.3 Weaknesses
  • 8.4 Opportunities
  • 8.5 Threats

9 Value Chain Analysis

10 Porters Five Forces Analysis

  • 10.1 Overview
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Degree of Competition
  • 10.5 Threat of New Entrants
  • 10.6 Threat of Substitutes

11 Price Analysis

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Agilent Technologies Inc.
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
      • 12.3.1.3 Financials
      • 12.3.1.4 SWOT Analysis
    • 12.3.2 Bio-Rad Laboratories Inc.
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
      • 12.3.2.3 Financials
      • 12.3.2.4 SWOT Analysis
    • 12.3.3 BioSolveIT GmbH
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
      • 12.3.3.3 Financials
    • 12.3.4 BIOVIA (Dassault Systemes)
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
    • 12.3.5 ChemAxon Inc.
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
    • 12.3.6 Eurofins CEREP SA (Eurofins Panlabs Inc.)
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
    • 12.3.7 Jubilant Biosys Inc.
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
    • 12.3.8 Molecular Discovery Ltd.
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
      • 12.3.8.3 Financials
    • 12.3.9 OpenEye Scientific Software Inc.
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio
    • 12.3.10 Schrodinger Inc.
      • 12.3.10.1 Company Overview
      • 12.3.10.2 Product Portfolio
      • 12.3.10.3 Financials

List of Figures

  • Figure 1: Global: Chemoinformatics Market: Major Drivers and Challenges
  • Figure 2: Global: Chemoinformatics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Chemoinformatics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Chemoinformatics Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Chemoinformatics Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Chemoinformatics (Chemical Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 7: Global: Chemoinformatics (Chemical Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 8: Global: Chemoinformatics (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Chemoinformatics (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Chemoinformatics (Drug Validation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Chemoinformatics (Drug Validation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Chemoinformatics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Chemoinformatics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: North America: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: North America: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: United States: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: United States: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Canada: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Canada: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Asia-Pacific: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Asia-Pacific: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: China: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: China: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Japan: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Japan: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: India: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: India: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: South Korea: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: South Korea: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Australia: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Australia: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Indonesia: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Indonesia: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Others: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Others: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Europe: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Europe: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Germany: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Germany: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: France: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: France: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United Kingdom: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United Kingdom: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Italy: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Italy: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Spain: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Spain: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Russia: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Russia: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Latin America: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Latin America: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Brazil: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Brazil: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Mexico: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Mexico: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Middle East and Africa: Chemoinformatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Middle East and Africa: Chemoinformatics Market: Breakup by Country (in %), 2025
  • Figure 62: Middle East and Africa: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Global: Chemoinformatics Industry: SWOT Analysis
  • Figure 64: Global: Chemoinformatics Industry: Value Chain Analysis
  • Figure 65: Global: Chemoinformatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Chemoinformatics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Chemoinformatics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 3: Global: Chemoinformatics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 4: Global: Chemoinformatics Market: Competitive Structure
  • Table 5: Global: Chemoinformatics Market: Key Players